Delivery Order SPE2DR25D3404-SPE2DR26F5U1M
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,180.52 on December 10, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units). This firm fixed-price delivery order, with an ultimate completion date of December 11, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The contract was competitively awarded with no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen auto-injectors with a ceiling value of $1,162.96 and a completion date of November 26, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and military...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,137.38 for Trulicity 1.5 mg/0.5 ml pen injectors on August 21, 2025, with completion scheduled for August 22, 2025. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical products...
- The Defense Logistics Agency awarded a $3,419.13 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors (0.5 ml). This firm fixed-price delivery order, with an ultimate completion date of June 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The award carries no set-aside designation and reflects...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors valued at $12,590.49. This non-competitive, firm fixed-price delivery order is expected to be completed by August 19, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,739.62 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen injectors on December 11, 2025. This firm fixed-price delivery order, with an ultimate completion date of December 12, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and performance will take place at the...
- The Defense Logistics Agency awarded a $3,184.17 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pen injectors on December 4, 2025, with an ultimate completion date of December 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors with a ceiling value of $15,344.90. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by November 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters and primary operations center....
- The Defense Logistics Agency awarded a $8,497.22 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen auto-injector supplies on November 7, 2025, with completion targeted for November 10, 2025. This firm fixed-price, non-set-aside delivery order represents a portion of AmerisourceBergen's broader pharmaceutical supply responsibilities under its larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's...
- SPE2DR25D3404Indefinite Delivery Contract
- SPE2DR25D3404-SPE2DR26F5U1MDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,616.66 for Trulicity 1.5 mg/0.5 ml pen auto-injectors on December 4, 2025, with completion expected by December 5, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical vendor supporting federal military and veteran healthcare systems through the DLA's Medical Supply Chain. The company's substantial IDC vehicle enables flexible procurement of brand-name and generic medications, specialty pharmaceuticals, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems globally. Trulicity, a diabetes management medication, represents the type of specialty pharmaceutical products routinely supplied through this comprehensive contract structure, which anticipates future transition to the DLA's Pharmaceutical Prime Vendor Global Program Generation V contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 12/3/25 |